Nabeshima, Kazuki
Fukuoka Tokushukai Hospital,
Japan
2025 Rank: 108386
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4149 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 108386 | 104755 |
| Total Cites | 7524 | 8739 |
| H-index | 40 | 45 |
| Hm-index | 16 | 18 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 75 | 87 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 1316 | 1454 |
| Number of Single+First+Last Authored Papers | 108 | 108 |
| Total Cites to Single+First+Last Authored Papers | 2994 | 3385 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6016 | 6507 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.34 |
| Self-Citation Percentage |
13.90%
|
|
Nabeshima, Kazuki
Fukuoka University Hospital,
Japan
2024 Rank: 108609
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4193 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 108609 | 103152 |
| Total Cites | 7032 | 8173 |
| H-index | 38 | 43 |
| Hm-index | 15 | 17 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 73 | 85 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 1284 | 1422 |
| Number of Single+First+Last Authored Papers | 107 | 107 |
| Total Cites to Single+First+Last Authored Papers | 2833 | 3211 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5633 | 6095 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.34 |
| Self-Citation Percentage |
13.96%
|
|
Nabeshima, Kazuki
Fukuoka Tokushukai Hospital,
Japan
2023 Rank: 104309
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4088 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 104309 | 102454 |
| Total Cites | 6532 | 7596 |
| H-index | 38 | 42 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 71 | 83 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 1250 | 1385 |
| Number of Single+First+Last Authored Papers | 105 | 105 |
| Total Cites to Single+First+Last Authored Papers | 2658 | 3005 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5257 | 5694 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.33 |
| Self-Citation Percentage |
14.01%
|
|
Nabeshima, Kazuki
Fukuoka University,
Japan
2022 Rank: 102927
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4049 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 102927 | 99579 |
| Total Cites | 5879 | 6856 |
| H-index | 36 | 40 |
| Hm-index | 14 | 16 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 68 | 80 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 1205 | 1339 |
| Number of Single+First+Last Authored Papers | 102 | 102 |
| Total Cites to Single+First+Last Authored Papers | 2434 | 2754 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4776 | 5188 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.32 |
| Self-Citation Percentage |
14.25%
|
|
Nabeshima, Kazuki
Fukuoka University School of Medicine,
Japan
2021 Rank: 98945
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3933 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 98945 | 99551 |
| Total Cites | 5662 | 6587 |
| H-index | 36 | 38 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 68 | 80 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 1179 | 1311 |
| Number of Single+First+Last Authored Papers | 100 | 100 |
| Total Cites to Single+First+Last Authored Papers | 2369 | 2677 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4600 | 4989 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.32 |
| Self-Citation Percentage |
14.04%
|
|
Nabeshima, Kazuki
Fukuoka University School of Medicine,
Japan
2020 Rank: 101521
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4165 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 101521 | 99563 |
| Total Cites | 5048 | 5851 |
| H-index | 32 | 35 |
| Hm-index | 13 | 15 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 64 | 76 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 1125 | 1255 |
| Number of Single+First+Last Authored Papers | 89 | 89 |
| Total Cites to Single+First+Last Authored Papers | 2114 | 2367 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4153 | 4502 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.30 |
| Self-Citation Percentage |
13.72%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.